Montes De Oca M, de Labastida Rivera F, Winterford C, Frame T, Ng S, Amante F, et al. IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection. PLoS Pathog. 2020;16:e1008994 pubmed publisher

Park H, Lim S, Hwang J, Zhang W, You S, Jin J. Cancer immunotherapy using a polysaccharide from Codium fragile in a murine model. Oncoimmunology. 2020;9:1772663 pubmed publisher

Laczkó D, Hogan M, Toulmin S, Hicks P, Lederer K, Gaudette B, et al. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020;53:724-732.e7 pubmed publisher

Loeuillard E, Yang J, Buckarma E, Wang J, Liu Y, Conboy C, et al. Targeting tumor-associated macrophages and granulocytic-myeloid-derived suppressor cells augments pd-1 blockade in cholangiocarcinoma. J Clin Invest. 2020;: pubmed publisher

Mandour M, Soe P, Uyttenhove C, Van Snick J, Marbaix E, Coutelier J. Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development. Infect Agent Cancer. 2020;15:30 pubmed publisher

Rana A, de Almeida F, Paico Montero H, Gonzales Carazas M, Bortoluci K, Sad S, et al. RIPK3 and Caspase-1/11 Are Necessary for Optimal Antigen-Specific CD8 T Cell Response Elicited by Genetically Modified Listeria monocytogenes. Front Immunol. 2020;11:536 pubmed publisher

Gladow N, Hollmann C, Ramos G, Frantz S, Kerkau T, Beyersdorf N, et al. Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction. PLoS ONE. 2020;15:e0227734 pubmed publisher

Takushi S, Paik N, Fedanov A, Prince C, Doering C, Spencer H, et al. Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects. Hum Gene Ther. 2020;31:626-638 pubmed publisher

Liu X, Wen J, Yi H, Hou X, Yin Y, Ye G, et al. Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release. Ther Adv Med Oncol. 2020;12:1758835920910347 pubmed publisher

Johnson A, Bullock B, Neuwelt A, Poczobutt J, Kaspar R, Li H, et al. Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. J Immunol. 2020;204:2295-2307 pubmed publisher

Chen Y, Wang Y, Lei C, Changou C, Davis M, Yen Y. Host immune response to anti-cancer camptothecin conjugated cyclodextrin-based polymers. J Biomed Sci. 2019;26:85 pubmed publisher

Sendler M, van den Brandt C, Glaubitz J, Wilden A, Golchert J, Weiss F, et al. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis. Gastroenterology. 2020;158:253-269.e14 pubmed publisher

Ngwenyama N, Salvador A, Velazquez F, NEVERS T, Levy A, Aronovitz M, et al. CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction. JCI Insight. 2019;4: pubmed publisher

Bailey S, Nelson M, Majchrzak K, Bowers J, Wyatt M, Smith A, et al. Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nat Commun. 2017;8:1961 pubmed publisher

Landi A, Law J, Hockman D, Logan M, Crawford K, Chen C, et al. Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Vaccine. 2017;35:6949-6956 pubmed publisher

Orlov M, Dmyterko V, Wurfel M, Mikacenic C. Th17 cells are associated with protection from ventilator associated pneumonia. PLoS ONE. 2017;12:e0182966 pubmed publisher

Ries M, Reynolds M, Bashkueva K, Crosno K, Capuano S, Prall T, et al. KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques. PLoS Pathog. 2017;13:e1006506 pubmed publisher

Ruland C, Renken H, Kuzmanov I, Fattahi Mehr A, Schwarte K, Cerina M, et al. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain Behav Immun. 2017;66:382-393 pubmed publisher

Meyer C, Key P, Zhu T, Shabsovich M, Ni A, Tripathy S. Expression of the inhibitory receptor NKG2A correlates with increased liver and splenic NK cell response to activating receptor engagement. Immun Inflamm Dis. 2017;5:177-189 pubmed publisher

Schridde A, Bain C, Mayer J, Montgomery J, Pollet E, Denecke B, et al. Tissue-specific differentiation of colonic macrophages requires TGFβ receptor-mediated signaling. Mucosal Immunol. 2017;10:1387-1399 pubmed publisher

BitMansour A, Pop L, Vitetta E. The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy. PLoS ONE. 2016;11:e0167618 pubmed publisher

Douthwaite J, Moisan J, Privezentzev C, Soskic B, Sabbah S, Cohen S, et al. A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding. J Immunol. 2017;198:528-537 pubmed

Marvin S, Russier M, Huerta C, Russell C, Schultz Cherry S. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function. J Virol. 2017;91: pubmed publisher

Mackroth M, Abel A, Steeg C, Schulze zur Wiesch J, Jacobs T. Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function. PLoS Pathog. 2016;12:e1005909 pubmed publisher

Theeß W, Sellau J, Steeg C, Klinke A, Baldus S, Cramer J, et al. Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection. Infect Immun. 2017;85: pubmed publisher

Gross C, Ahmetspahic D, Ruck T, Schulte Mecklenbeck A, Schwarte K, Jörgens S, et al. Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e289 pubmed

Al Attar A, Presnell S, Peterson C, Thomas D, Lutz C. Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans. Data Brief. 2016;8:536-44 pubmed publisher

Nice T, Osborne L, Tomov V, Artis D, Wherry E, Virgin H. Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity. PLoS Pathog. 2016;12:e1005684 pubmed publisher

Joosten S, van Meijgaarden K, Del Nonno F, Baiocchini A, Petrone L, Vanini V, et al. Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment. PLoS Pathog. 2016;12:e1005687 pubmed publisher

Vacaflores A, Chapman N, Harty J, Richer M, Houtman J. Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism. PLoS ONE. 2016;11:e0157175 pubmed publisher

Krishna B, Lau B, Jackson S, Wills M, Sinclair J, Poole E. Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells. Sci Rep. 2016;6:24674 pubmed publisher

Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug G, Sauder U, et al. The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol. 2016;196:106-14 pubmed publisher

Ren Y, Min Y, Liu M, Chi L, Zhao P, Zhang X. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses. Biochim Biophys Acta. 2016;1860:1764-75 pubmed publisher

Bunse C, Borchers S, Varanasi P, Tischer S, Figueiredo C, Immenschuh S, et al. Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor. PLoS ONE. 2013;8:e77925 pubmed publisher

Li D, Cai W, Gu R, Zhang Y, Zhang H, Tang K, et al. Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients. Clin Immunol. 2013;149:411-20 pubmed publisher

Asgari E, Le Friec G, Yamamoto H, Perucha E, Sacks S, Köhl J, et al. C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood. 2013;122:3473-81 pubmed publisher

Fiorenza S, Kenna T, Comerford I, McColl S, Steptoe R, Leggatt G, et al. A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin. J Immunol. 2012;189:5622-31 pubmed publisher

Janune D, Kubota S, Nishida T, Kawaki H, Perbal B, Iida S, et al. Novel effects of CCN3 that may direct the differentiation of chondrocytes. FEBS Lett. 2011;585:3033-40 pubmed publisher

Munk R, Sugiyama K, Ghosh P, Sasaki C, Rezanka L, Banerjee K, et al. Antigen-independent IFN-γ production by human naïve CD4 T cells activated by IL-12 plus IL-18. PLoS ONE. 2011;6:e18553 pubmed publisher

Wood M, Breitschwerdt E, Gookin J. Autocrine effects of interleukin-6 mediate acute-phase proinflammatory and tissue-reparative transcriptional responses of canine bladder mucosa. Infect Immun. 2011;79:708-15 pubmed publisher

Mattarollo S, Yong M, Tan L, Frazer I, Leggatt G. Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen. J Immunol. 2010;184:5663-9 pubmed publisher

Yang M, Sun L, Wang S, Ko K, Xu H, Zheng B, et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol. 2010;184:3321-5 pubmed publisher

Mattarollo S, Rahimpour A, Choyce A, Godfrey D, Leggatt G, Frazer I. Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production. J Immunol. 2010;184:1242-50 pubmed publisher

Liu X, Leerberg J, MacDonald K, Leggatt G, Frazer I. IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol. 2009;183:51-8 pubmed publisher

Durkin E, Jones K, Rajesh D, Shaaban A. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood. 2008;112:5245-53 pubmed publisher